Literature DB >> 9003372

Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction.

H Kaneto1, J Fujii, T Myint, N Miyazawa, K N Islam, Y Kawasaki, K Suzuki, M Nakamura, H Tatsumi, Y Yamasaki, N Taniguchi.   

Abstract

Several reducing sugars brought about apoptosis in isolated rat pancreatic islet cells and in the pancreatic beta-cell-derived cell line HIT. This apoptosis was characterized biochemically by inter-nucleosomal DNA cleavage and morphologically by nuclear shrinkage, chromatin condensation and apoptotic body formation. N-Acetyl-L-cysteine, an antioxidant, and aminoguanidine, an inhibitor of the glycation reaction, inhibited this apoptosis. We also showed directly that proteins in beta-cells were actually glycated by using an antibody which can specifically recognize proteins glycated by fructose, but not by glucose. Furthermore, fluorescence-activated cell sorting analysis using dichlorofluorescein diacetate showed that reducing sugars increased intracellular peroxide levels prior to the induction of apoptosis. Levels of carbonyl, an index of oxidative modification, and of malondialdehyde, a lipid peroxidation product, were also increased. Taken together, these results suggest that reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress mainly through the glycation reaction, which may explain the deterioration of beta-cells under conditions of diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003372      PMCID: PMC1218007          DOI: 10.1042/bj3200855

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms.

Authors:  G W Gould; H M Thomas; T J Jess; G I Bell
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

Review 2.  Free radicals, antioxidants, and human disease: where are we now?

Authors:  B Halliwell; J M Gutteridge; C E Cross
Journal:  J Lab Clin Med       Date:  1992-06

3.  Determination of carbonyl content in oxidatively modified proteins.

Authors:  R L Levine; D Garland; C N Oliver; A Amici; I Climent; A G Lenz; B W Ahn; S Shaltiel; E R Stadtman
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine.

Authors:  D Edelstein; M Brownlee
Journal:  Diabetes       Date:  1992-01       Impact factor: 9.461

5.  Agents that elevate cAMP stimulate DNA fragmentation in thymocytes.

Authors:  D J McConkey; S Orrenius; M Jondal
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

6.  Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes.

Authors:  C J Mullarkey; D Edelstein; M Brownlee
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

7.  Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose.

Authors:  G Suárez; R Rajaram; A L Oronsky; M A Gawinowicz
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

8.  Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1.

Authors:  F A Oberhammer; M Pavelka; S Sharma; R Tiefenbacher; A F Purchio; W Bursch; R Schulte-Hermann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

Authors:  S Picard; S Parthasarathy; J Fruebis; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.

Authors:  R Schreck; P Rieber; P A Baeuerle
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  55 in total

Review 1.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

2.  Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2004-11-10

Review 3.  Small-molecule inhibition of inflammatory β-cell death.

Authors:  M Lundh; S S Scully; T Mandrup-Poulsen; B K Wagner
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

Review 4.  Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.

Authors:  Hideaki Kaneto; Naoto Katakami; Munehide Matsuhisa; Taka-aki Matsuoka
Journal:  Mediators Inflamm       Date:  2010-02-16       Impact factor: 4.711

Review 5.  Advanced-glycation end products in insulin-resistant states.

Authors:  Georgia Soldatos; Mark E Cooper; Karin A M Jandeleit-Dahm
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

6.  Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Authors:  Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

7.  Absence of a reductase, NCB5OR, causes insulin-deficient diabetes.

Authors:  Jianxin Xie; Hao Zhu; Kevin Larade; Annie Ladoux; Ayden Seguritan; Michelle Chu; Susumu Ito; Roderick T Bronson; Edward H Leiter; Chen-Yu Zhang; Evan D Rosen; H Franklin Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

8.  Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus.

Authors:  M Koyama; R Wada; H Sakuraba; H Mizukami; S Yagihashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.

Authors:  M Novelli; B Bonamassa; M Masini; N Funel; D Canistro; V De Tata; M Martano; A Soleti; D Campani; M Paolini; P Masiello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-29       Impact factor: 3.000

10.  Effects of soybean isoflavone extract on the plasma lipid profiles and antioxidant enzyme activity in streptozotocin-induced diabetic rats.

Authors:  Jee-Youn Shim; Yoo Jung Kim; Hye-Sung Lee
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.